Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
KW-2246 for breakthrough cancer pain
NCT01326689Phase 3Completed
- Sponsor
- Kyowa Kirin
- Start
- Mar 2011
- Primary completion
- Jun 2012
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of fentanyl in breakthrough cancer pain (BTcP), sponsored by Kyowa Kirin. Started Mar 2011; status: completed.
02
Drugs
fentanyl
03
Conditions
breakthrough cancer pain (BTcP)
Beyond the preview
Go deeper on NCT01326689.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01326689.